Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.


He will remain in post until early July, focusing on key priorities including the medical training review for postgraduate doctors, improvements in stroke care, and commitments to ongoing inquiries.

Professor Powis was appointed national medical director of NHS England in 2018, following 12 years as medical director at the Royal Free NHS Trust.

He played a critical role in the NHS’s response to the COVID-19 pandemic, leading the health service through an unprecedented crisis, supporting frontline workers, and advising the public in numerous government briefings.

Notably, he was present when the first-ever COVID vaccine was administered to Maggie Keenan in December 2020.

During his tenure, Professor Powis has led several national reviews and overseen the development and implementation of major healthcare programmes, including national cardiovascular, respiratory, and stroke initiatives.

He also played a key role in creating the first national patient safety strategy and the rollout of medical examiners.

Reflecting on his time in the role, Professor Powis said: “It has been an immense privilege to serve as national medical director for the NHS and I am incredibly grateful to have been supported by amazing colleagues working across the NHS to boost the experiences of patients.

“I have always been exceptionally proud to work in the NHS and while stepping down from this role, I remain passionate and committed to improving the health of patients and improving the experience of staff.

Pritchard praised Professor Powis as “a dedicated public servant as well as a brilliant and kind colleague.”

“His contribution to the NHS and the country was enormous during the pandemic. I am hugely grateful – as I know our colleagues, friends and families are too – for the vital role he played leading the medical profession’s response to a once in a century health emergency,” she said.

Health Secretary Wes Streeting also acknowledged Professor Powis’s leadership, particularly in the COVID vaccine rollout and the creation of the national patient safety strategy

He stated: “Steve has provided outstanding clinical leadership to the NHS over the last eight years, including during the biggest health emergency our country has faced in modern history.

“His knowledge, professionalism, and guidance helped the NHS rise to the challenges created by the pandemic.”

Professor Powis’s departure follows Pritchard’s recent decision to stand down as NHS England’s chief executive at the end of this financial year.

Sir James Mackey, currently chief executive of Newcastle Hospitals NHS Foundation Trust and national director of Elective Recovery, will take over as transition CEO before officially assuming the role on 1 April.

Meanwhile, Dr Penny Dash was appointed as the next chair of NHS England, succeeding Richard Meddings, who is set to step down next month.

Under this new leadership, Streeting is set to publish the 10-Year Plan for Health, which aims to combine investment with reform to build an NHS fit for the future.

More For You

Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less
Scotland's digital patient care record

The amendment ensures that every person who receives health care or a social service in Scotland will have a digital care record

Pic credit: iStock

Scotland's move to create digital patient care record hailed

The Royal Pharmaceutical Society (RPS) in Scotland has welcomed the decision of the Scottish Parliament to create an integrated digital patient care record.

The move came during a debate on the Care Reform (Scotland) Bill on Tuesday (10), when Jackie Baillie tabled an amendment to ensure that every person who receives health care or a social service in Scotland has a digital care record.

Keep ReadingShow less
A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less